Abdelhakim Belkacem-Ahmed

Inserm U955, Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.

Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.

Journal: Antimicrobial agents and chemotherapy

Published: July 17, 2026

Role of respiratory small extracellular vesicles in Respiratory Syncytial Virus infection

Role of respiratory small extracellular vesicles in Respiratory Syncytial Virus infection

Journal: Virologie (Montrouge, France)

Published: November 03, 2025

Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronaviruses.

Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronaviruses.

Journal: Veterinary research

Published: May 07, 2025

Picomolar bivalent inhibitors of protein kinase CK2 active against β-coronavirus replication.

Picomolar bivalent inhibitors of protein kinase CK2 active against β-coronavirus replication.

Journal: European journal of medicinal chemistry

Published: April 16, 2025

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity.

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity.

Journal: International journal of molecular sciences

Published: March 24, 2023

The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia-reperfusion injury via mitoprotection.

The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia-reperfusion injury via mitoprotection.

Journal: JHEP reports : innovation in hepatology

Published: February 24, 2023

Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.

Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.

Journal: Viruses

Published: March 31, 2022

Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.

Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.

Journal: Journal of extracellular vesicles

Published: March 11, 2022

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.

Journal: Scientific reports

Published: January 12, 2022

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Journal: Cancer discovery

Published: November 03, 2021

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Journal: Cell death and differentiation

Published: January 30, 2021

Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.

Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.

Journal: European journal of gastroenterology & hepatology

Published: November 19, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026